Skip to main content

Peer Review reports

From: COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

Original Submission
24 Mar 2010 Submitted Original manuscript
22 Jun 2010 Reviewed Reviewer Report - Steven Albelda
7 Jul 2010 Reviewed Reviewer Report - Tijmen Korteweg
17 Jul 2010 Reviewed Reviewer Report - Cor van der Leest
3 Aug 2010 Author responded Author comments - joost hegmans
Resubmission - Version 2
3 Aug 2010 Submitted Manuscript version 2
16 Aug 2010 Reviewed Reviewer Report - Cor van der Leest
17 Aug 2010 Reviewed Reviewer Report - Steven Albelda
24 Aug 2010 Author responded Author comments - joost hegmans
Resubmission - Version 3
24 Aug 2010 Submitted Manuscript version 3
26 Aug 2010 Author responded Author comments - joost hegmans
Resubmission - Version 4
26 Aug 2010 Submitted Manuscript version 4
Publishing
30 Aug 2010 Editorially accepted
30 Aug 2010 Article published 10.1186/1471-2407-10-464

You can find further information about peer review here.

Back to article page